|
1
|
Townsend N, Wilson L, Bhatnagar P,
Wickramasinghe K, Rayner M and Nichols M: Cardiovascular disease in
Europe Epidemiological update 2016. Eur Heart J. 37:3232–3245.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Graham RM, Frazier DP, Thompson JW, Haliko
S, Li H, Wasserlauf BJ, Spiga MG, Bishopric NH and Webster KA: A
unique pathway of cardiac myocyte death caused by hypoxia-acidosis.
J Exp Biol. 207:3189–3200. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kemp CD and Conte JV: The pathophysiology
of heart failure. Cardiovasc Pathol. 21:365–371. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambrosy AP, Fonarow GC, Butler J, Chioncel
O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN
and Gheorghiade M: The global health and economic burden of
hospitalizations for heart failure: Lessons learned from
hospitalized heart failure registries. J Am Coll Cardiol.
63:1123–1133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie F, Wu CF, Lai WP, Yang XJ, Cheung PY,
Yao XS, Leung PC and Wong MS: The osteoprotective effect of Herba
epimedii (HEP) extract in vivo and in vitro. Evid Based Complement
Alternat Med. 2:353–361. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen M, Wu J, Luo Q, Mo S, Lyu Y, Wei Y
and Dong J: The anticancer properties of Herba epimedii and its
main bioactive componentsicariin and icariside II. Nutrients.
8:E5632016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu S, Li YL, Wu YT, Yue Y, Qian ZQ and
Yang DL: Icariside II attenuates myocardial fibrosis by inhibiting
nuclear factor-κB and the TGF-β1/Smad2 signalling pathway in
spontaneously hypertensive rats. Biomed Pharmacother. 100:64–71.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Peng C, Xia J, Zhang W, Tian L,
Tian Y, Yang X and Cao Y: Effects of icariside II ameliorates
diabetic cardiomyopathy in streptozotocin-induced diabetic rats by
activating Akt/NOS/NF-κB signaling. Mol Med Rep. 17:4099–4105.
2018.
|
|
10
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boon RA and Dimmeler S: MicroRNAs in
myocardial infarction. Nat Rev Cardiol. 12:135–142. 2015.
View Article : Google Scholar
|
|
13
|
Gu Y, Liang Z, Wang H, Jin J, Zhang S, Xue
S, Chen J, He H, Duan K, Wang J, et al: Tanshinone IIA protects
H9c2 cells from oxidative stress-induced cell death via
microRNA-133 upregulation and Akt activation. Exp Ther Med.
12:1147–1152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang G, Wu H, Hu Y, Li J and Li Q:
Gastrodin inhibits glutamate-induced apoptosis of PC12 cells via
inhibition of CaMKII/ASK-1/p38 MAPK/p53 signaling cascade. Cell Mol
Neurobiol. 34:591–602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kalinowski FC, Brown RA, Ganda C, Giles
KM, Epis MR, Horsham J and Leedman PJ: microRNA-7: A tumor
suppressor miRNA with therapeutic potential. Int J Biochem Cell
Biol. 54:312–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li B, Li R, Zhang C, Bian HJ, Wang F, Xiao
J, Liu SW, Yi W, Zhang MX, Wang SX, et al: MicroRNA-7a/b protects
against cardiac myocyte injury in ischemia/reperfusion by targeting
poly(ADP-ribose) polymerase. PLoS One. 9:e900962014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Song J, Feng L, Zhong R, Xia Z, Zhang L,
Cui L, Yan H, Jia X and Zhang Z: Icariside II inhibits the EMT of
NSCLC cells in inflammatory microenvironment via down-regulation of
Akt/NF-κB signaling pathway. Mol Carcinog. 56:36–48. 2017.
View Article : Google Scholar
|
|
19
|
Khan M, Maryam A, Qazi JI and Ma T:
Targeting apoptosis and multiple signaling pathways with icariside
II in cancer cells. Int J Biol Sci. 11:1100–1112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao J, Deng Y, Yin C, Liu Y, Zhang W, Shi
J and Gong Q: Icariside II, a novel phosphodiesterase 5 inhibitor,
protects against H2 O2 -induced PC12 cells
death by inhibiting mitochondria-mediated autophagy. J Cell Mol
Med. 21:375–386. 2017. View Article : Google Scholar
|
|
21
|
Li J, Qiu M, An Y, Huang J and Gong C:
miR-7-5p acts as a tumor suppressor in bladder cancer by regulating
the hedgehog pathway factor Gli3. Biochem Biophys Res Commun.
503:2101–2107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu W, Wang Y, Zhang D, Yu X and Leng X:
MiR-7-5p functions as a tumor suppressor by targeting SOX18 in
pancreatic ductal adenocarcinoma. Biochem Biophys Res Commun.
497:963–970. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Giles KM, Brown RA, Ganda C, Podgorny MJ,
Candy PA, Wintle LC, Richardson KL, Kalinowski FC, Stuart LM, Epis
MR, et al: microRNA-7-5p inhibits melanoma cell proliferation and
metastasis by suppressing RelA/NF-κB. Oncotarget. 7:31663–31680.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zou L, Ma X, Lin S, Wu B, Chen Y and Peng
C: Long noncoding RNA-MEG3 contributes to myocardial
ischemia-reperfusion injury through suppression of miR-7-5p
expression. Biosci Rep. 39:BSR201902102019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Buanne P, Corrente G, Micheli L, Palena A,
Lavia P, Spadafora C, Lakshmana MK, Rinaldi A, Banfi S, Quarto M,
et al: Cloning of PC3B, a novel member of the PC3/BTG/TOB family of
growth inhibitory genes, highly expressed in the olfactory
epithelium. Genomics. 68:253–263. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yuniati L, Scheijen B, van der Meer LT and
van Leeuwen FN: Tumor suppressors BTG1 and BTG2: Beyond growth
control. J Cell Physiol. 234:5379–5389. 2019. View Article : Google Scholar :
|
|
27
|
Tong Z, Jiang B, Wu Y, Liu Y, Li Y, Gao M,
Jiang Y, Lv Q and Xiao X: MiR-21 protected cardiomyocytes against
doxorubicin-induced apoptosis by targeting BTG2. Int J Mol Sci.
16:14511–14525. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leszczynska KB, Foskolou IP, Abraham AG,
Anbalagan S, Tellier C, Haider S, Span PN, O'Neill EE, Buffa FM and
Hammond EM: Hypoxia-induced p53 modulates both apoptosis and
radiosensitivity via AKT. J Clin Invest. 125:2385–2398. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bell RM and Yellon DM: Bradykinin limits
infarction when administered as an adjunct to reperfusion in mouse
heart: The role of PI3K, Akt and eNOS. J Mol Cell Cardiol.
35:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Keyes KT, Xu J, Long B, Zhang C, Hu Z and
Ye Y: Pharmacological inhibition of PTEN limits myocardial infarct
size and improves left ventricular function postinfarction. Am J
Physiol Heart Circ Physiol. 298:H1198–H1208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu W, Mao L, Ji F, Chen F, Wang S and Xie
Y: Icariside II activates EGFR-Akt-Nrf2 signaling and protects
osteoblasts from dexamethasone. Oncotarget. 8:2594–2603. 2017.
View Article : Google Scholar :
|
|
32
|
Liu ML, Zhang Q, Yuan X, Jin L, Wang LL,
Fang TT and Wang WB: Long noncoding RNA RP4 functions as a
competing endogenous RNA through miR-7-5p sponge activity in
colorectal cancer. World J Gastroenterol. 24:1004–1012. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu Z, Wang Y, Xiong J, Cui F, Wang L and
Peng H: NUSAP1 knockdown inhibits cell growth and metastasis of
non-small-cell lung cancer through regulating BTG2/PI3K/Akt
signaling. J Cell Physiol. 235:3886–3893. 2019. View Article : Google Scholar : PubMed/NCBI
|
